These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2441164)

  • 1. Cardiovascular actions in vitro and cardioprotective effects in vivo of nileprost, a mixed type PGI2/PGE2 agonist.
    Darius H; Thomsen T; Schrör K
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):144-52. PubMed ID: 2441164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of antiplatelet effects from myocardial cytoprotective activity during acute myocardial ischemia in cats by a new carbacyclin derivative (ZK 36 375).
    Schrör K; Darius H; Ohlendorf R; Matzky R; Klaus W
    J Cardiovasc Pharmacol; 1982; 4(4):554-61. PubMed ID: 6181328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia.
    Schrör K; Ohlendorf R; Darius H
    J Pharmacol Exp Ther; 1981 Oct; 219(1):243-9. PubMed ID: 6169823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evaluation of 5-(Z,E)-13,14-didehydro-20-methyl-carboprostacyclin (FCE 22509).
    Ceserani R; Grossoni M; Ukmar G; Colombo M; Mongelli N
    Prostaglandins Leukot Med; 1986 Mar; 21(3):231-45. PubMed ID: 3517883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the protective effect of prostacyclin in acute myocardial ischemia.
    Ogletree ML; Lefer AM; Smith JB; Nicolaou KC
    Eur J Pharmacol; 1979 Jun; 56(1-2):95-103. PubMed ID: 467518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of platelet aggregation by 13-azaprostanoic acid in acute myocardial ischemia and sudden death.
    Burke SE; Roth DM; Lefer AM
    Thromb Res; 1983 Mar; 29(5):473-88. PubMed ID: 6857596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of prostacyclin prevents ventricular fibrillation following coronary occlusion in conscious dogs.
    Starnes VA; Primm RK; Woosley RL; Oates JA; Hammon JW
    J Cardiovasc Pharmacol; 1982; 4(5):765-9. PubMed ID: 6182407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia.
    Lefer AM; Ogletree ML; Smith JB; Silver MJ; Nicolaou KC; Barnette WE; Gasic GP
    Science; 1978 Apr; 200(4337):52-4. PubMed ID: 345441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of prostacyclin on coronary thrombosis and myocardial ischemia in conscious canine experiments.
    Fiedler VB; Mardin M
    Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):114-27. PubMed ID: 3913392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation.
    Simpson PJ; Mitsos SE; Ventura A; Gallagher KP; Fantone JC; Abrams GD; Schork MA; Lucchesi BR
    Am Heart J; 1987 Jan; 113(1):129-37. PubMed ID: 3541554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of the ischemic myocardium from reperfusion injury by prostaglandin E1 inhibition of ischemia-induced neutrophil activation.
    Schrör K; Thiemermann C; Ney P
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):268-74. PubMed ID: 2848205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and late administration of a PGI2-analogue, ZK 36 374 (iloprost): effects on myocardial preservation, collateral blood flow and infarct size.
    Smith EF; Gallenkämper W; Beckmann R; Thomsen T; Mannesmann G; Schrör K
    Cardiovasc Res; 1984 Mar; 18(3):163-73. PubMed ID: 6200229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium and myocardial protecting actions of taprostene, a stable prostacyclin analogue, after acute myocardial ischemia and reperfusion in cats.
    Johnson G; Furlan LE; Aoki N; Lefer AM
    Circ Res; 1990 May; 66(5):1362-70. PubMed ID: 2159389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous prostacyclin preserves myocardial function and endothelium-derived nitric oxide formation in myocardial ischemia.
    Schrör K; Woditsch I
    Agents Actions Suppl; 1992; 37():312-9. PubMed ID: 1632306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular responses to PGI2 (prostacyclin) in the dog.
    Fitzpatrick TM; Alter I; Corey EJ; Ramwell PW; Rose JC; Kot PA
    Circ Res; 1978 Feb; 42(2):192-4. PubMed ID: 340081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. dl-9a-Deoxy-9a-methylene-PGI2 (a stable prostacyclin derivative): preliminary pharmacological data.
    Ceserani R; Grossoni M; Longiave D; Mizzotti B; Pozzi O; Dembinska-Kiec A; Bianco S
    Prostaglandins Med; 1980 Aug; 5(2):131-9. PubMed ID: 6251496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed antiischemic effect of prostaglandin I2 and of a new stable prostaglandin I2 analogue, 7-oxo-prostacyclin-Na, in experimental model angina in dogs.
    Szekeres L; Krassói I; Pataricza J; Udvary E
    Adv Myocardiol; 1985; 6():607-18. PubMed ID: 3887531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of defibrotide in protecting ischemic myocardium from early reperfusion damage.
    Thiemermann C; Löbel P; Schrör K
    Am J Cardiol; 1985 Dec; 56(15):978-82. PubMed ID: 3907318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostacyclin rather than endogenous nitric oxide is a tissue protective factor in myocardial ischemia.
    Woditsch I; Schrör K
    Am J Physiol; 1992 Nov; 263(5 Pt 2):H1390-6. PubMed ID: 1443194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.